Cytrellis Biosystems, Inc. ("Cytrellis") a medical aesthetics company bridging the gap in skin health and restoration, announced that its ellacor (R) System with Micro-Coring (R) Technology has been ...
Houston-based double board-certified plastic surgeon expands hair restoration program with breakthrough noninvasive technology from Lumenis HOUSTON, TX / ACCESS Newswire / April 15, 2026 / Dr. Janak ...
Houston-based double board-certified plastic surgeon expands hair restoration program with breakthrough noninvasive ...
According to BCC Research, rising demand for aesthetic procedures, skin disease treatment, and advanced diagnostic ...
With just two days remaining, bidding activity is expected to increase in the Online Auction. If you’ve been watching ...
Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...
Gregory Martin, DDS, MS discusses the HALO TRIIBRID, a laser system that simultaneously targets skin texture, tone, and ...
The One Big Beautiful Bill Act was signed into law by President Donald Trump on July 4, 2025. Now, one grandmother says she's ...
Since Iran closed the Strait of Hormuz on February 28, 2026, the global oil market has been volatile. U.S. and Israeli ...
KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track de ...
Positions Combined Company to Lead in AI InfrastructureAcceptance Period Commences Today and Ends on May 9, 2026Rumble Has Secured Commitments ...
Kymera Therapeutics (KYMR) stays a Strong Buy on KT-621 Phase 1b AD results, FDA Fast Track, and $1.6B cash runway—click to ...